Skip to content

Clinical trials

Terminated Idiopathic Pulmonary Fibrosis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Idiopathic Pulmonary Fibrosis Status: Terminated Country / region: Canada Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20111
20121
20131
20172
20181
20212
20221
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences3
Celgene2
Hoffmann-La Roche2
Amgen1
Boehringer Ingelheim1
Genentech, Inc.1
GlaxoSmithKline1
Lakefront Biotherapeutics NV1
MedImmune LLC1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Idiopathic Pulmonary Fibrosis15
Pulmonary Fibrosis4
Fibrosis3
Lung Diseases, Interstitial3
Hypertension, Pulmonary1
Idiopathic Interstitial Pneumonias1
Lung Diseases1
Pathologic Processes1
Respiratory Tract Diseases1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.